100065
二苯基硼酸-2-氨基乙酯
≥97% (titration), crystalline solid, Ins(1,4,5)P3-induced Ca2+ release inhibitor, Calbiochem®
别名:
二苯基硼酸-2-氨基乙酯, 2-氨基乙氧基二苯基硼酸酯，（2-氨基乙氧基）二苯基硼烷
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C14H16BNO
化学文摘社编号:
分子量:
225.09
UNSPSC Code:
12352200
NACRES:
NA.77
MDL number:
Assay:
≥97% (titration)
Form:
crystalline solid
Quality level:
Storage condition:
OK to freeze, desiccated (hygroscopic)
产品名称
二苯基硼酸-2-氨基乙酯, A cell-permeable modulator of Ins(1,4,5)P3-induced Ca2+ release.
Quality Level
description
Drug Control: Új pszichoaktív anyag / New psychoactive substance (Hungary), 78/2022. (XII. 28.) BM rendelet, RTECS - ED6150000
assay
≥97% (titration)
form
crystalline solid
manufacturer/tradename
Calbiochem®
drug control
Új pszichoaktív anyag / New psychoactive substance (Hungary), 78/2022. (XII. 28.) BM rendelet
storage condition
OK to freeze, desiccated (hygroscopic)
color
white
solubility
DMSO: 20 mg/mL, 95% ethanol: 25 mg/mL
shipped in
ambient
storage temp.
2-8°C
SMILES string
B(OCCN)(c2ccccc2)c1ccccc1
InChI
1S/C14H16BNO/c16-11-12-17-15(13-7-3-1-4-8-13)14-9-5-2-6-10-14/h1-10H,11-12,16H2
InChI key
BLZVCIGGICSWIG-UHFFFAOYSA-N
General description
Ins（1,4,5）P3诱导Ca2+释放的细胞渗透性调节剂。可抑制大鼠小脑微粒体中Ins（1,4,5）P3诱导的Ca2+释放（IC50 = 42 µM），且不会影响[3H]-Ins（1,4,5）P3 与其受体的结合。在肝细胞中，2-APB可通过一种可能涉及其与通道蛋白或相关调节蛋白结合的机制，来抑制Ca2+库通道。其对Ca2+从对精氨酸敏感的Ca2+库（由大鼠腿部骨骼肌和心脏中制备得到）中释放没有影响。
Biochem/physiol Actions
主要靶标
Ins（1,4,5）P3诱导的Ca2+释放
Ins（1,4,5）P3诱导的Ca2+释放
产物不与ATP竞争。
可逆：否
细胞可渗透性：具有
靶标IC50：42 µM，抑制Ins（1,4,5）P3诱导的大鼠小脑微粒体制剂中Ca2+的释放
Packaging
用惰性气体包装
Preparation Note
溶解后，等分并冷冻保存（-20°C）。储备溶液在-20°C下可稳定保存2个月。
Other Notes
Brooke, R. T., et al. 2004.Lab. Invest.84, 29.
Gregory, R.B., et al. 2001.Biochem.J.354, 285.
Ma, H.T., et al. 2001.J. Biol. Chem.276, 18888.
Ascher-Landsberg, S., et al. 1999.Biochem.Biophys.Res. Commun.264, 979.
Maruyama, T., et al. 1997.J. Biochem.122, 498.
Gregory, R.B., et al. 2001.Biochem.J.354, 285.
Ma, H.T., et al. 2001.J. Biol. Chem.276, 18888.
Ascher-Landsberg, S., et al. 1999.Biochem.Biophys.Res. Commun.264, 979.
Maruyama, T., et al. 1997.J. Biochem.122, 498.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
毒性：标准处理（A）
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Dominic D Quintana et al.
Journal of Alzheimer's disease : JAD, 75(1), 119-138 (2020-04-07)
Cerebrovascular pathology is pervasive in Alzheimer's disease (AD), yet it is unknown whether cerebrovascular dysfunction contributes to the progression or etiology of AD. In human subjects and in animal models of AD, cerebral hypoperfusion and hypometabolism are reported to manifest
Wook-Joo Lee et al.
Frontiers in immunology, 12, 772941-772941 (2021-12-21)
Dry skin is a symptom of skin barrier dysfunction that evokes pruritus; however, the cutaneous neuroimmune interactions underlying dry skin-induced pruritus remain unclear. Therefore, we aimed to elucidate the mechanisms underlying dry skin-induced pruritus. To this end, an acetone/ethanol/water (AEW)-induced
Jinyu Zhang et al.
International journal of molecular sciences, 23(22) (2022-11-27)
Dry eye disease (DED) is a multifactorial disease with an incidence of approximately 50% worldwide. DED seriously affects quality of life and work. The prevalence of environmental DED (eDED) ranges from 35 to 48%. Conjunctival fluid secretion dysfunction may be
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 100065-100MG | 07790788056766 |